Identifying a malignant B-cell lymphoma clone in peripheral blood using immunoglobulin high-throughput sequencing and lineage tree analysis.

Abstract

International Journal of Laboratory HematologyVolume 44, Issue 5 p. e239-e242 LETTER TO THE EDITOR Identifying a malignant B-cell lymphoma clone in peripheral blood using immunoglobulin high-throughput sequencing and lineage tree analysis Meirav Kedmi, Corresponding Author Meirav Kedmi meirav.kedmi@sheba.health.gov.il orcid.org/0000-0001-9175-8551 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel Correspondence Meirav Kedmi, Head of Lymphoma Service, Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center at Tel Hashomer, Ramat Gan 5262100, Israel. Email: meirav.kedmi@sheba.health.gov.ilSearch for more papers by this authorHadas Neuman, Hadas Neuman The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, IsraelSearch for more papers by this authorGuy Bitansky, Guy Bitansky Sackler School of Medicine, Tel-Aviv University, Tel Aviv, IsraelSearch for more papers by this authorMeital Nagar, Meital Nagar Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, IsraelSearch for more papers by this authorGaelle Scheinert-Shenhav, Gaelle Scheinert-Shenhav Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, IsraelSearch for more papers by this authorIris Barshack, Iris Barshack Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, IsraelSearch for more papers by this authorGinette Schiby, Ginette Schiby Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, IsraelSearch for more papers by this authorHilla Tabibian-Keissar, Hilla Tabibian-Keissar Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, IsraelSearch for more papers by this authorAbraham Avigdor, Abraham Avigdor Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel Sackler School of Medicine, Tel-Aviv University, Tel Aviv, IsraelSearch for more papers by this authorRamit Mehr, Ramit Mehr The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, IsraelSearch for more papers by this author Meirav Kedmi, Corresponding Author Meirav Kedmi meirav.kedmi@sheba.health.gov.il orcid.org/0000-0001-9175-8551 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel Correspondence Meirav Kedmi, Head of Lymphoma Service, Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center at Tel Hashomer, Ramat Gan 5262100, Israel. Email: meirav.kedmi@sheba.health.gov.ilSearch for more papers by this authorHadas Neuman, Hadas Neuman The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, IsraelSearch for more papers by this authorGuy Bitansky, Guy Bitansky Sackler School of Medicine, Tel-Aviv University, Tel Aviv, IsraelSearch for more papers by this authorMeital Nagar, Meital Nagar Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, IsraelSearch for more papers by this authorGaelle Scheinert-Shenhav, Gaelle Scheinert-Shenhav Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, IsraelSearch for more papers by this authorIris Barshack, Iris Barshack Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, IsraelSearch for more papers by this authorGinette Schiby, Ginette Schiby Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, IsraelSearch for more papers by this authorHilla Tabibian-Keissar, Hilla Tabibian-Keissar Department of Pathology, Chaim Sheba Medical Center, Ramat Gan, IsraelSearch for more papers by this authorAbraham Avigdor, Abraham Avigdor Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel Sackler School of Medicine, Tel-Aviv University, Tel Aviv, IsraelSearch for more papers by this authorRamit Mehr, Ramit Mehr The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, IsraelSearch for more papers by this author First published: 15 June 2022 https://doi.org/10.1111/ijlh.13906Citations: 1 Funding information: Janssen Pharmaceuticals, Grant/Award Number: Oncology Grant; United States-Israel Binational Science Foundation, Grant/Award Number: 20130432; Bar-Ilan University Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume44, Issue5October 2022Pages e239-e242 RelatedInformation